Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

AllianzGI Health Sciences Fund

+ Add to Watchlist

DGHCX:US

37.83 USD 0.18 0.47%

As of 09:29:30 ET on 04/24/2015.

Snapshot for AllianzGI Health Sciences Fund (DGHCX)

Year To Date: +16.22% 3-Month: +11.72% 3-Year: +27.76% 52-Week Range: 26.88 - 38.01
1-Month: +1.42% 1-Year: +38.55% 5-Year: +20.08% Beta vs MXWO0HC: 1.10

Mutual Fund Chart for DGHCX

No chart data available.
  • DGHCX:US 37.83
  • 1M
  • 1Y
Interactive DGHCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DGHCX

AllianzGI Health Sciences Fund is open-end fund incorporated in the USA. The Fund seeks long-term capital appreciation. The Fund invests in the equity securities of health care companies of any size located in at least three different countries, which may include the United States.

Inception Date: 12-31-1996 Telephone: 1-888-852-3922
Managers: MICHAEL DAUCHOT / JOHN SCHROER
Web Site: www.allianzinvestors.com

Fundamentals for DGHCX

NAV (on 2015-04-24) 37.83
Assets (M) (on 2015-03-31) 206.35
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 50.00

Dividends for DGHCX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-11) 2.98
Dividend Yield (ttm) 13.11

Fees & Expenses for DGHCX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.20
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.46

Top Fund Holdings for DGHCX

Filing Date: 01/31/2015
Name Position Value % of Total
Actavis plc 32,470 8,654,554 4.616%
Mallinckrodt PLC 76,915 8,152,221 4.348%
Celgene Corp 57,270 6,824,293 3.640%
Johnson & Johnson 64,605 6,469,545 3.451%
Merck & Co Inc 102,085 6,153,684 3.282%
Vertex Pharmaceuticals Inc 54,274 5,977,738 3.188%
Shire PLC 80,025 5,840,855 3.115%
Boston Scientific Corp 384,570 5,695,482 3.038%
Biogen Inc 13,875 5,399,595 2.880%
Sanofi 116,765 5,381,699 2.870%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil